Literature DB >> 7769244

Pristane induces high titers of anti-Su and anti-nRNP/Sm autoantibodies in BALB/c mice. Quantitation by antigen capture ELISAs based on monospecific human autoimmune sera.

M Satoh1, E L Treadwell, W H Reeves.   

Abstract

Autoantibodies to Su and anti-nRNP/Sm are common in human and murine systemic lupus erythematosus (SLE), and are also produced by BALB/c mice with SLE-like autoimmunity induced by pristane. Antigen capture ELISAs employing monospecific human autoimmune IgG were developed to quantitate the production of anti-Su and anti-nRNP/Sm autoantibodies in 77 sera from BALB/c mice with pristane-induced autoimmunity. The sensitivity and specificity of the anti-Su antigen capture ELISA were 100% compared with immunoprecipitation of 35S-labeled cellular proteins. All 16 immunoprecipitation positive sera were positive in the anti-nRNP/Sm antigen capture ELISA (100% sensitivity), whereas 55/61 immunoprecipitation negative sera were negative by ELISA (90% specificity). The 6/61 immunoprecipitation negative sera that were ELISA positive were probably true positives because subsequent sera obtained from the same mice were positive by both techniques. Thus, the antigen capture ELISA may be somewhat more sensitive than immunoprecipitation. The titers of anti-Su and anti-nRNP/Sm positive antibodies in the sera were as high as 1:25,000-1:250,000 by ELISA, suggesting that autoantibodies may be produced in pristane-primed BALB/c mice at levels comparable to those seen in spontaneous autoimmune disease. We conclude that antigen capture ELISAs based on human autoimmune sera were highly sensitive and specific for detecting murine anti-Su and anti-nRNP/Sm antibodies. This technique will be useful for quantitating antibodies in murine autoimmune disease models, since antigen capture ELISA avoids the use of denatured or recombinant antigens, permitting antibodies recognizing tertiary and quaternary structures to be detected.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7769244     DOI: 10.1016/0022-1759(95)00022-3

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  11 in total

1.  Detection of the argonaute protein Ago2 and microRNAs in the RNA induced silencing complex (RISC) using a monoclonal antibody.

Authors:  Keigo Ikeda; Minoru Satoh; Kaleb M Pauley; Marvin J Fritzler; Westley H Reeves; Edward K L Chan
Journal:  J Immunol Methods       Date:  2006-10-04       Impact factor: 2.303

2.  Temporal evolution of human autoantibody response to cytoplasmic rods and rings structure during anti-HCV therapy with ribavirin and interferon-α.

Authors:  Gerson Dierley Keppeke; Minoru Satoh; Maria Lucia Gomes Ferraz; Edward K L Chan; Luís Eduardo C Andrade
Journal:  Immunol Res       Date:  2014-10       Impact factor: 2.829

3.  Effects of adjuvants for human use in systemic lupus erythematosus (SLE)-prone (New Zealand black/New Zealand white) F1 mice.

Authors:  E Favoino; E I Favia; L Digiglio; V Racanelli; Y Shoenfeld; F Perosa
Journal:  Clin Exp Immunol       Date:  2014-01       Impact factor: 4.330

Review 4.  Pristane-induced lupus: considerations on this experimental model.

Authors:  Eduarda Correa Freitas; Mayara Souza de Oliveira; Odirlei André Monticielo
Journal:  Clin Rheumatol       Date:  2017-09-06       Impact factor: 2.980

5.  Induction of hypergammaglobulinemia and macrophage activation by silicone gels and oils in female A.SW mice.

Authors:  J O Naim; M Satoh; N A Buehner; K M Ippolito; H Yoshida; D Nusz; L Kurtelawicz; S F Cramer; W H Reeves
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

6.  Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane.

Authors:  M Satoh; A Kumar; Y S Kanwar; W H Reeves
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

Review 7.  CD20-Mimotope Peptide Active Immunotherapy in Systemic Lupus Erythematosus and a Reappraisal of Vaccination Strategies in Rheumatic Diseases.

Authors:  Elvira Favoino; Marcella Prete; Andrea Marzullo; Enrico Millo; Yehuda Shoenfeld; Federico Perosa
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

8.  Interleukin 6 dependence of anti-DNA antibody production: evidence for two pathways of autoantibody formation in pristane-induced lupus.

Authors:  H B Richards; M Satoh; M Shaw; C Libert; V Poli; W H Reeves
Journal:  J Exp Med       Date:  1998-09-07       Impact factor: 14.307

9.  Cluster of systemic lupus erythematosus (SLE) associated with an oil field waste site: a cross sectional study.

Authors:  James Dahlgren; Harpreet Takhar; Pamela Anderson-Mahoney; Jenny Kotlerman; Jim Tarr; Raphael Warshaw
Journal:  Environ Health       Date:  2007-02-22       Impact factor: 5.984

10.  Immunopathogenesis of environmentally induced lupus in mice.

Authors:  V M Shaheen; M Satoh; H B Richards; H Yoshida; M Shaw; J C Jennette; W H Reeves
Journal:  Environ Health Perspect       Date:  1999-10       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.